Asklepion Pharmaceuticals

    OverviewSuggest Edit

    Asklepion Pharmaceuticals is a biopharmaceutical company specializing in rare pediatric diseases. It focuses on the discovery, development, and commercialization of pharmaceutical products for acute lung injury induced by cardiopulmonary bypass and acute sickle cell crisis.

    TypePrivate
    Founded2006
    HQBaltimore, MD, US
    Websiteasklepionpharm.com

    Latest Updates

    Employees (est.) (Feb 2021)7(-12%)
    Cybersecurity ratingAMore

    Key People/Management at Asklepion Pharmaceuticals

    Gary Pasternack

    Gary Pasternack

    Chief Executive Officer (C.E.O.)
    Jeff Courtney

    Jeff Courtney

    Managing Director and Chief Operating Officer
    Gurdyal Kalsi

    Gurdyal Kalsi

    Chief Medical Officer
    Gary Pyner

    Gary Pyner

    Director of Commercial Affairs
    Keith Ryan

    Keith Ryan

    Director of Regulatory Affairs
    Elizabeth Monnot-Chase

    Elizabeth Monnot-Chase

    Director of CMC, Quality
    Show more

    Asklepion Pharmaceuticals Office Locations

    Asklepion Pharmaceuticals has an office in Baltimore
    Baltimore, MD, US (HQ)
    729 E Pratt St #360
    Show all (1)

    Asklepion Pharmaceuticals Financials and Metrics

    Summary Metrics

    Founding Date

    2006

    Asklepion Pharmaceuticals Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    94/100

    SecurityScorecard logo

    Asklepion Pharmaceuticals Online and Social Media Presence

    Embed Graph

    Asklepion Pharmaceuticals News and Updates

    Asklepion Pharmaceuticals LLC announces AWINSA Life Sciences as its Clinical safety and Pharmacovigilance Service provider for their clinical trials in their fight against COVID-19

    PRINCETON, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AWINSA Life Sciences, a Pharmacovigilance and Clinical Safety service provider announced that it has been selected as the preferred vendor for clinical safety management by Asklepion, a biopharmaceutical company for their upcoming trials.

    Asklepion Pharmaceuticals Frequently Asked Questions

    • When was Asklepion Pharmaceuticals founded?

      Asklepion Pharmaceuticals was founded in 2006.

    • Who are Asklepion Pharmaceuticals key executives?

      Asklepion Pharmaceuticals's key executives are Gary Pasternack, Jeff Courtney and Gurdyal Kalsi.

    • How many employees does Asklepion Pharmaceuticals have?

      Asklepion Pharmaceuticals has 7 employees.

    • Who are Asklepion Pharmaceuticals competitors?

      Competitors of Asklepion Pharmaceuticals include Biogen, Inovio Pharmaceuticals and Athersys.

    • Where is Asklepion Pharmaceuticals headquarters?

      Asklepion Pharmaceuticals headquarters is located at 729 E Pratt St #360, Baltimore.

    • Where are Asklepion Pharmaceuticals offices?

      Asklepion Pharmaceuticals has an office in Baltimore.

    • How many offices does Asklepion Pharmaceuticals have?

      Asklepion Pharmaceuticals has 1 office.